Top Abstract Purchase Related
Home
>
Node
>
Subnode

Comparison between diurnal changes and changes induced by hydrocortisone and epinephrine in circulating myeloid progenitor cells (CFU-GM) in man

Morra, L.; Ponassi, A.; Caristo, G.; Bruzzi, P.; Bonelli, A.; Zunino, R.; Parodi, G.B.; Sacchetti, C.

Biomedicine and PharmacoTherapy 38(3): 167-170

1984

ISSN/ISBN: 0753-3322
PMID: 6541067
Document Number: 231505
A significant increase from 8 AM to 3 PM was found in both myeloid progenitor cell (CFU-GM) and polymorphonuclear leukocyte (PMN) blood concentration in 45 normal subjects. Diurnal blood (CFU-GM and PMN changes were significantly correlated. Spontaneous diurnal changes in blood CFU-GM levels and in PMN were compared with the changes induced by i. v. administration of hydrocortisone (16 normal volunteers) and of epinephrine (10 normal volunteers). Diurnal changes in CFU-GM and PMN seem to follow a pattern similar to that induced by epinephrine administration. These findings suggest that diurnal changes in CFU-GM reflect mainly a shift of these cells between different blood compartments.

Document emailed within 1 workday
Secure & encrypted payments

Sagaster, V.; Jäger, E.; Weltermann, A.; Schwarzinger, I.; Gisslinger, H.; Lechner, K.; Geissler, K.; Oehler, L. 2003: Circulating hematopoietic progenitor cells predict survival in patients with myelofibrosis with myeloid metaplasia Haematologica 88(11): 1204-1212
Grimaz, S.; Damiani, D.; Michieli, M.; Baccarani, M. 2000: Mobilization of peripheral blood progenitor cells with G-CSF alone in lymphoma patients: steady-state circulating progenitor cell count predicts the autograft yield Haematologica 85(1): 102-103
Zambelli, A.; Poggi, G.; Da Prada, G.; Pedrazzoli, P.; Cuomo, A.; Miotti, D.; Perotti, C.; Preti, P.; Robustelli della Cuna, G. 1998: Clinical toxicity of cryopreserved circulating progenitor cells infusion Anticancer Research 18(6b): 4705-4708
Pospísil, M.; Vacek, A.; Hofer, M.; Viklická, S.; Pipalová, I.; Sandula, J. 1993: Hyporesponsiveness of murine myeloid progenitor cells to glucan following its repeated administration Folia Biologica 39(4): 178-187
Majolino, I.; Marcenò, R.; Buscemi, F.; Scimè, R.; Vasta, S.; Indovina, A.; Pampinella, M.; Catania, P.; Santoro, A. 1995: Mobilization of circulating progenitor cells in multiple myeloma during VCAD therapy with or without rhG-CSF Haematologica 80(2): 108-114
Patrick KY Goon; Watson, T.; Gregory YH Lip 2007: Editorial: New Frontiers in Cardiovascular Disease: Circulating Endothelial Cells and Endothelial Progenitor Cells as Cellular Biomarkers Clinical Laboratory 53(5-6): 297-299
Buscemi, F.; Fabbiano, F.; Felice, R.; DiNoto, R.; Cappuzzo, V.; Majolino, I.; Caronia, F. 1993: Use of large polygonal contiguous gates for flow cytometry analysis of circulating progenitor cells Bone Marrow Transplantation 12(3): 305-306
Machalińska, A.; Kotowski, M.; Safranow, K.; Lewandowska, J.; Modrzejewska, M.; Rudnicki, J.; Czajka, R.; Machaliński, B.ła. 2011: The role of circulating endothelial progenitor cells in the progression of retinopathy of prematurity--a prospective study Klinika Oczna 113(7-9): 223-227
Li, Q.-z.; Han, J.-j.; Chen, H.; Mo, X.-l.; Xia, Z.-h.; Qian, Z.-j. 2013: Reduced circulating endothelial progenitor cells is a risk factor of coronary slow flow Zhonghua Xin Xue Guan Bing Za Zhi 41(1): 44-47
Bel'chenko, D.I.; Zinov'ev, I.V.; Simkin, D.S. 1972: Effect of hydrocortisone on indices of energy metabolism of erythroid and myeloid cells of the rabbit bone marrow Biulleten' Eksperimental'noi Biologii i Meditsiny 73(5): 17-20
Mergenthaler, H.G.; Brühl, P.; Dörmer, P. 1988: Kinetics of myeloid progenitor cells in human micro long-term bone marrow cultures Experimental Hematology 16(2): 145-149
Koizumi, S.; Fine, R.L.; Curt, G.A.; Griffin, J.D.; Chabner, B.A. 1985: Enrichment of myeloid progenitor cells from normal human bone marrow using an immune-rosette technique Experimental Hematology 13(6): 560-565
D'Arena, G.; Carotenuto, M. 1998: More on the appropriate fluorochrome-conjugated CD34 antibody choice for the flow cytometric detection of circulating progenitor cells Haematologica 83(1): 93-94
Patrone, F.; Ballestrero, A.; Balleari, E.; Bogliolo, F.; Brema, F.; Ferrando, F.; Ghio, R.; Timitilli, S. 1992: High-dose cyclophosphamide followed by GM-CSF is a safe and effective procedure for the recruitment of trilineage circulating progenitor cells Haematologica 77(6): 457-462
Martín-Henao, G.A.; Inglés-Esteve, J.; Cancelas, J.A.; García, J. 1996: Isolation of CD34+ hematopoietic progenitor cells in chronic myeloid leukemia by magnetic activated cell sorting (MACS) Bone Marrow Transplantation 18(3): 603-609
Wendling, F.; Vigon, I.; Souyri, M.; Tambourin, P. 1989: Myeloid progenitor cells transformed by the myeloproliferative leukemia virus proliferate and differentiate in vitro without the addition of growth factors Leukemia 3(7): 475-480
Fitchen, J.H.; Ferrone, S.; Lusis, A.J.; Cline, M.J. 1980: Cytotoxicity of anti-beta 2-microglobulin xenoantisera to human and murine myeloid progenitor cells and lack of cross-reactivity with colony-stimulating activity Journal of Immunology 124(6): 2906-2908
Johnsen, H.E.; Hansen, P.B.; Plesner, T.; Jensen, L.; Gaarsdal, E.; Andersen, H.; Hansen, S.W.; Birgens, H.; Jacobsen, G.K.; Kjaersgaard, E. 1992: Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor Bone Marrow Transplantation 10(3): 229-234
Numata, M.; Koizumi, S.; Horita, S.; Ueno, Y.; Yamagami, M.; Taniguchi, N. 1985: Different Ia antigen characterization between granulocyte progenitor cells (CFC-G) and monocyte-macrophage progenitor cells (CFC-M) Experimental Hematology 13(8): 827-832
Mustjoki, S.; Sidenius, N.; Sier, C.F.; Blasi, F.; Elonen, E.; Alitalo, R.; Vaheri, A. 2000: Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy Cancer Research 60(24): 7126-7132